No, but you're drawing a conclusion that I think is not fair to the industry and I don't think is representative of the legislation.
I would like to point out another thing that you talked about, respecting the double standard about Health Canada. You've given the interpretation that you would basically have a double standard, such that drugs would go out to other countries without having the Canadian seal of approval. But at the same time, those countries could choose to use their own drug policy. All the bill does is allow a country that may, for example, use the USFDA or the European Union or the World Health Organization.... What's the problem with allowing that? You're suggesting a drug would be made in Canada that is not for sale to Canadian people but then goes through another screening process for another country.